Skip to content
FTHFTH

INDICATIONS

Applicable Cancers

Diseases for which Japan’s QST Hospital publicly lists carbon ion therapy. Select a cancer type to see its coverage category in Japan, number of fractions, and a brief description.

Staged image representing a particle accelerator facility
AI-generated staged image

The number of fractions depends on the location and condition of the cancer. Select a cancer type for details.

Skull Base TumorsSkull Base Tumor16 fractionsHead and Neck CancerHead & Neck Cancer16 fractionsEye TumorsChoroidal Melanoma4 fractionsBone and Soft Tissue TumorsBone & Soft Tissue Sarcoma8–16 fractionsProstate CancerProstate Cancer12 fractionsEsophageal CancerEsophageal Cancer8 or 12 fractionsLung CancerLung Cancer1–16 fractionsLiver CancerLiver Cancer2 or 4 fractionsPancreatic CancerPancreatic Cancer12 fractionsKidney CancerRenal Cell Carcinoma12 fractionsColorectal CancerColorectal Cancer16 fractionsGynecologic CancerGynecologic Cancer16 or 20 fractionsMetastatic TumorsMetastatic Tumor1–16 fractionsBreast CancerBreast Cancer4 fractions

The above is a summary of QST Hospital’s (Chiba, Japan) official pages 「重粒子線治療の適応」 (https://hospital.qst.go.jp/patients/indications/index.html) and 「重粒子線治療の適応疾患、重粒子線の特徴、当院の実績、紹介方法について」 (https://www.qst.go.jp/site/hospital/professionals-information.html, updated July 16, 2026). Insurance categories follow the Japanese system. The number of fractions varies with the lesion and treatment plan, and eligibility is determined by the physicians of the medical institution.